Neuropsychiatric Drug Development Summit Boston
Evvnt Promotion / evvnt
Archiv
23.07.2019 - 25.07.2019 Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, USA
Time: 8:00 am - 4:30 pm
Kongressthemen
With the huge unmet clinical need in neuropsychiatry and despite multiple approved pharmaceuticals available, the development of the next generation of neuropsychiatric drugs is essential.
Historically, drug development within neuropsychiatry has been stifled for decades by a lack of scientific progress in the neuropsychiatric field combined with costly and challenging clinical trials.
With the huge unmet clinical need in neuropsychiatry and despite multiple approved pharmaceuticals available, the development of the next generation of neuropsychiatric drugs is essential.
Historically, drug development within neuropsychiatry has been stifled for decades by a lack of scientific progress in the neuropsychiatric field combined with costly and challenging clinical trials.
Kongressorganizer (PCO)
NPD | Hanson Wade
NPD | Hanson Wade
Anfragen und Anmeldung:
https://go.evvnt.com/389254-1?pid=4832
Herr Marie Bourdon
Allgemeinmedizin
Sprache
Englisch
Englisch
Kongressgebühr
USD 4.396,00
(Gold: Conference and 3 workshops: USD 4396.0, Silver: Conference and 2 workshops: USD 3897.0, Bronze: Conference and 1 workshop: USD 3398.0, Conference only: USD 2799.0, Workshop only: USD 699.0)
USD 4.396,00
(Gold: Conference and 3 workshops: USD 4396.0, Silver: Conference and 2 workshops: USD 3897.0, Bronze: Conference and 1 workshop: USD 3398.0, Conference only: USD 2799.0, Workshop only: USD 699.0)
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
